These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25038431)

  • 21. 5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
    Urushidani S; Kuriyama A; Matsumura M
    J Gastroenterol Hepatol; 2018 Jan; 33(1):12-19. PubMed ID: 28623877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical therapy in right-sided diverticulitis].
    Hildebrand P; Birth M; Bruch HP; Schwandner O
    Zentralbl Chir; 2005 Apr; 130(2):123-7. PubMed ID: 15849655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
    Ford AC; Khan KJ; Sandborn WJ; Hanauer SB; Moayyedi P
    Clin Gastroenterol Hepatol; 2012 May; 10(5):513-9. PubMed ID: 22083024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
    Tursi A; Brandimarte G; Daffinà R
    Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminosalicylates.
    Gross V
    Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.
    Kruis W; Meier E; Schumacher M; Mickisch O; Greinwald R; Mueller R;
    Aliment Pharmacol Ther; 2013 Apr; 37(7):680-90. PubMed ID: 23414061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
    Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
    Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverticulitis: new insights on the traditional point of view.
    Moubax K; Urbain D
    Acta Gastroenterol Belg; 2015; 78(1):38-48. PubMed ID: 26118576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
    Brandimarte G; Tursi A
    Med Sci Monit; 2004 May; 10(5):PI70-3. PubMed ID: 15114281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis.
    Stollman N; Smalley W; Hirano I;
    Gastroenterology; 2015 Dec; 149(7):1944-9. PubMed ID: 26453777
    [No Abstract]   [Full Text] [Related]  

  • 33. Balsalazide in treating colonic diseases.
    Tursi A
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1555-63. PubMed ID: 19708827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
    Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.
    Tursi A; Brandimarte G; Giorgetti GM; Elisei W; Aiello F
    Int J Colorectal Dis; 2007 Sep; 22(9):1103-8. PubMed ID: 17390144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical inquiries: How can you help prevent a recurrence of diverticulitis?
    Weisberger L; Jamieson B
    J Fam Pract; 2009 Jul; 58(7):381-2. PubMed ID: 19607778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
    Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
    Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily, high-concentration MMX mesalamine in active ulcerative colitis.
    Kamm MA; Sandborn WJ; Gassull M; Schreiber S; Jackowski L; Butler T; Lyne A; Stephenson D; Palmen M; Joseph RE
    Gastroenterology; 2007 Jan; 132(1):66-75; quiz 432-3. PubMed ID: 17241860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension.
    Dughera L; Serra AM; Battaglia E; Tibaudi D; Navino M; Emanuelli G
    Minerva Gastroenterol Dietol; 2004 Jun; 50(2):149-53. PubMed ID: 15722985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.